Equities

Broncus Holding Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Broncus Holding Corp

Actions
Health CareMedical Equipment and Services
  • Price (HKD)1.37
  • Today's Change0.00 / 0.00%
  • Shares traded285.00k
  • 1 Year change+92.96%
  • Beta0.9321
Data delayed at least 15 minutes, as of Mar 05 2026 03:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Broncus Holding Corp is an investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

  • Revenue in HKD (TTM)47.54m
  • Net income in HKD-118.50m
  • Incorporated2012
  • Employees193.00
  • Location
    Broncus Holding CorpRoom 801, 8/F, Building 8No. 88 Jiangling Road, Xixing StreetBinjiang DistrictHANGZHOU ChinaCHN
  • Websitehttps://www.broncus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Austar Lifesciences Ltd1.66bn40.00m399.81m1.45k10.000.43474.080.24070.0780.0783.241.790.70174.861.541,149,300.001.584.003.519.1220.1822.092.264.391.1674.460.30590.00-14.937.42149.3114.728.35--
Rainmed Medical Ltd26.55m-118.21m406.39m214.00--0.7349--15.31-0.1009-0.10090.02260.39460.04231.194.6398,324.88-19.20---23.73--44.22---454.20--2.38--0.0766---45.61--2.02------
ClouDr Group Ltd2.56bn-1.08bn477.83m966.00--0.4369--0.1864-1.82-1.824.341.690.86552.953.462,104,725.00-38.96-79.82-70.33--33.5026.37-45.01-74.910.9896-60.820.2871---5.4946.08-59.85--78.43--
Vincent Medical Holdings Ltd869.70m87.51m652.67m1.46k7.281.045.040.75050.1360.1361.350.95420.92263.303.96654,893.109.7210.3213.9714.9534.4734.7710.5310.251.55--0.204937.1011.569.7920.7643.1026.3224.57
Broncus Holding Corp47.54m-118.50m785.35m193.00--0.6253--16.52-0.2443-0.24430.0982.380.03470.43140.855237,716.30-8.65-44.03-8.96-46.7772.3676.11-249.25-849.5926.33--0.0003---20.710.145845.52---2.79--
BioSino Bio-technology and Science Inc255.76m-53.78m790.10m471.00--4.64--3.09-0.3717-0.37171.771.180.46332.411.59512,537.70-12.66-2.01-33.54-5.4638.7739.79-27.32-3.720.7174-5.030.477---9.00-7.92-265.14---3.59--
China Health Group Ltd39.87m-60.77m887.77m127.00------22.26-0.0992-0.09920.065-0.0290.20522.021.76269,412.20-31.41-16.08-261.02-42.3022.7928.29-153.08-44.720.7455-22.53-----35.02-2.92-68.69--30.06--
Gaush Meditech Ltd1.64bn115.79m903.59m819.007.760.46974.350.55240.78750.787511.1413.010.5352.089.051,850,454.003.62-1.534.67-2.2047.2947.666.77-2.901.578.160.2188--1.585.24-46.75--79.78--
Kaisa Health Group Holdings Ltd166.42m-31.22m1.01bn917.00--2.31--6.06-0.0062-0.00620.0330.08650.3086.691.52193,284.50-6.59-7.25-7.83-9.3441.5845.27-21.40-28.203.89--0.0257---0.2824-5.93-720.72---19.69--
Venus MedTech HangZhou Inc485.53m-730.25m1.06bn605.00--0.4526--2.19-1.67-1.671.115.320.12180.90652.08702,651.20-18.34-13.83-21.01-15.5775.8378.74-150.57-151.551.56-32.630.1928---4.1815.08-1.50--11.12--
Shanghai Bio-heart Biologicl Tech Co Ltd23.71m-101.51m1.16bn70.00--2.14--48.87-0.417-0.4170.09742.230.02510.84353.43376,314.70-11.04-30.86-12.96-32.9946.47---439.71--11.95-1.470.203------50.00--25.75--
Beijing Airdoc Technology Co Ltd166.34m-200.72m1.17bn193.00--0.8208--7.06-1.96-1.961.6313.960.10021.572.80589,846.10-12.54-12.40-13.31-13.5466.2956.72-125.12-128.078.71--0.0098---23.3438.74-92.75--1.28--
Data as of Mar 05 2026. Currency figures normalised to Broncus Holding Corp's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.09%Per cent of shares held by top holders
HolderShares% Held
SSgA Funds Management, Inc.as of 05 Feb 2026459.00k0.09%
UBS Asset Management (Hong Kong) Ltd.as of 30 Jun 20250.000.00%
China Universal Asset Management Co., Ltd.as of 30 Jun 20250.000.00%
Data from 28 Nov 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.